Multicenter open-label study with infliximab in active ankylosing spondylitis over 28 weeks in daily practice. [electronic resource]
Producer: 20080728Description: 247-52 p. digitalISSN:- 0392-856X
- Activities of Daily Living
- Acute Disease
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antirheumatic Agents -- administration & dosage
- Employment
- Female
- Health Status
- Humans
- Infliximab
- Male
- Middle Aged
- Private Practice
- Prospective Studies
- Quality of Life
- Spondylitis, Ankylosing -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.